The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I.e. the only opinion is the sp outcome for tomorrow - the rest are all undisputed facts/posts/outcomes
No Mark it's stating facts this time
Gap up at open, RNS coming, TR1 coming, sp up 30%, sp up to 20p, sp up to 30p, NT, NT, NT, takeover coming, DHL, Wincanton, Girteka all coming, £106m liquidity, brand worth more than the mcap, shorter will burn, Tinkler selling is good, sellers are out !
End result - sp down 13.89 % as per London Stock Exchange closing price
https://www.londonstockexchange.com/exchange/prices-and-markets/stocks/summary/company-summary/GB00BD8QVC95GBGBXASQ1.html?lang=en
My forecast for tomorrow ?
Gap up at open, RNS coming, TR1 coming, sp up 30%, sp up to 20p, sp up to 30p, NT, NT, NT, takeover coming, DHL, Wincanton, Girteka all coming, £106m liquidity, brand worth more than the mcap, shorter will burn, Tinkler selling is good, sellers are out !
End result - probably another 5-10% drop
Good luck all - you will need it
@rebs348 - you did right mate as I suspect you were already running on empty in that regard, a bit like ESl's balance sheet lol
@Rebs348 - again I have already explained, selling at 12p having bought at 76p felt great - as I had only expected to get 6p and saw the price drop to 4.7p. Finding out in August 2019 that ESL had been suspended felt like crap and even worse when it became clear that rather lose 50% I was probable going to have to write that investment off almost completely. Since then I have moved on and the double your money to 12p was a nice surprise ! Ant that's more than the closing price tonight lol
@Rebs348 - You are bout the fifth person who has stated this incorrectly - ESL does not own the Stobart brand - It is owned by Stobart Group - STOB - a totally different company - ESL pay STOB £3m to use the brand. So the brand has a negative value of £3m per annum in outgoing cash to ESL not a positive value on the balance sheet
Very good summary HeresHoping - and trust me DBAY only care about DBAY
@Bertie, agreed I may miss out on a lot of short term growth - it's the old risk and reward - tbh I had decided to hold and risk but with CV I fear that all the bankers will go into conservative mode and with so little time to raise funds that might become a problem. Dealt with bankers on a fundraising last year myself and their lack of competence and total conservatism was breathtaking. Hope it works out for you.
@Pokerchips - also agree, if I was providing finance I would want to see lessons learned. Having said that it is always hard to do something new and people shouldn't be shot for not quite getting there as some of the stuff TRX are doing is groundbreaking and no doubt incredibly difficult to do.
@Bertie - I can buy back in after funding secured, all be it at a much higher price but with much less risk and still massive potential over the long term, is how I see it
Gareth could have bought before he took the Interim CEO role as he joined in October 2018 - John could have bought more as the share price reduced and the cash started to run out but chose not to. Agree sales are growing and that is no easy task to do hence why I see value but am cautious
Nailed it Hereshopin - the equity buy out was too risky so they went the way of controlling the debt to protect their equity investment via the PIK loan
@Scarlett - Shame they weren't as desperate as their shareholders in the period August 2017 2019 - or have they been in a closed period for 2.5 years ? Excuse my ignorance if that is the case, I didn't realise I was out of touch with the closed period rules lol
Hi Bertie, totally agree, my point is they had plenty of opportunity since August 2017 to buy and have not done so.
@Stocksbof52 - you don't even know what £106m liquidity means
@ Rebs348 - the sell price tonight is 11.5p lol I did ok thanks with the hand I had
@Stocksbof52 - Fair do on the spelling, can be tricky with big fingers. But on AT he gives a monkey about every £5 he can make, I know because I have negotiated with him so of course I know the whole story - but you are confusing his court battle with STOB and this is ESL - he has not been at ESL since it was floated by DBAY, other than as a representative of STOB. They are two different companies you know ! If they sell TPN or anything else it will be used to pay down debt, probably including the PIK load, it won't to shareholders in dividends.
@Jarv55 - Sebastien is no longer there lol and that report is well old and irrelevant
@Stocksbof52 - I almost understood the gist of your post - If you knew Andrew Tinkler you would know that he has a very thick skin and does not care what people think of him - his view is his record speaks for itself. So the only reason he would sell or hold is to make money - and he sold - so that explains his thinking. He is not an idiot when it comes to buying and selling, whether that be shares or anything else.
@HeresHopin - that made me chuckle like a drain - thanks for bringing some levity atb
Unless TRX Directors have been buying shares and not declaring such, which would of course be against FCA rules, it appears none of them have had the confidence since August 2017 to buy a single share ? I wonder why PI's have been so supportive when the Directors and Management have been ?
In addition the following article from September 2019 may be worth a read
https://finance.yahoo.com/news/investors-bought-tissue-regenix-group-144132169.html
@stocksbof52 - I think what hillbilly is asking is why so many of your facts, predictions and forecasts are wrong ? I guess it is a question we are all asking ?